Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
Globe Newswire28-02-2023, 20:00
Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint 12-06-2024, 09:06